University of Pittsburgh at CTAD 2026
Nov 16–19, 2026 Boston, MA ~1.7k attendees Website
University of Pittsburgh takes part in 4 sessions at CTAD 2026 in Boston. Its program centres on tau, measured in blood and with PET. Its work compares four tau PET tracers with plasma p-tau217 and develops brain-selective plasma assays for early tau pathology.
| Organization | CTAD 2026 Attendance |
|---|---|
University of Pittsburgh Pittsburgh, Pennsylvania | |
Its researchers co-developed the Pittsburgh compound B amyloid PET tracer; also runs an Alzheimer's Disease Research Center. | Poster Wed Nov 18 7:15am–5:30pm Poster Wed Nov 18 7:15am–5:30pm Talk Wed Nov 18 4:15pm |
Instantly find 20 buyers from University of Pittsburgh
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction